---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-070340"
form_type: "8-K"
ticker: "HYPR"
cik: "0001833769"
company_name: "Hyperfine, Inc."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T17:30:23.487807+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Hyperfine Q1 revenue $2.1M, down 36% YoY; net loss $9.4M; guides FY25 growth 10-20%

## Summary
- Q1 revenue $2.1M vs $3.3M YoY; sold 6 commercial Swoop systems.
- Net loss $9.4M ($0.12/share) vs $9.8M ($0.14/share) YoY; gross margin 41.3%.
- Guidance: H1 2025 rev ~$5-6M; FY25 revenue growth 10-20% over 2024.
- Cash burn forecast $25-28M in FY25 (31% decline at midpoint); raised $6M in registered direct offering.
- Submitted next-gen Swoop technology to FDA; started NEURO PMR study for neurology offices.

## SEC filing metadata
- accession: 0000950170-25-070340
- form_type: 8-K
- ticker: HYPR
- cik: 0001833769
- company_name: Hyperfine, Inc.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833769/000095017025070340/0000950170-25-070340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833769/000095017025070340/hypr-20250513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-070340
- JSON: https://secwatch.observer/filing/0000950170-25-070340.json
- Plain text: https://secwatch.observer/filing/0000950170-25-070340.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.